Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net income (loss)	$ 2,695,549	$ (5,056,328)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	5,317,414	$ 7,084,715
Provision for bad debts	49,605
(Gain) loss on sale of assets	(642)	$ 74,099
Stock issued for services	694,693	1,119,721
Fair market value of warrants and stock options granted	145,716	466,866
Changes in operating assets and liabilities:
Accounts receivable	115,428	(2,369,950)
Accounts receivable - related party	(3,111,316)	(198,640)
Revenues in excess of billing	(3,248,121)	(2,734,788)
Other current assets	(838,913)	188,048
Accounts payable and accrued expenses	617,112	1,008,270
Unearned revenue	(1,305,724)	2,984,297
Net cash provided by operating activities	1,130,801	2,566,310
Cash flows from investing activities:
Purchases of property and equipment	(2,523,865)	(2,499,314)
Sales of property and equipment	556,280	$ 209,718
Investment	(555,556)
Purchase of subsidiary shares from open market	(767,397)	$ (577,222)
Net cash used in investing activities	(3,290,538)	(2,866,818)
Cash flows from financing activities:
Proceeds from sale of common stock	64,931	1,863,000
Proceeds from the exercise of stock options and warrants	728,699	116,400
Proceeds from exercise of subsidiary options	$ 16,744	12,306
Restricted cash		2,438,844
Dividend paid by subsidiary to Non controlling interest		$ (780,106)
Proceeds from bank loans	$ 1,334,285
Payments on capital lease obligations and loans - net	(736,405)	$ (3,459,143)
Net cash provided by financing activities	1,408,254	191,301
Effect of exchange rate changes	(1,536,315)	(466,130)
Net decrease in cash and cash equivalents	(2,287,798)	(575,337)
Cash and cash equivalents, beginning of the period	14,168,957	11,462,695
Cash and cash equivalents, end of period	11,881,159	10,887,358
SUPPLEMENTAL DISCLOSURES:
Interest	195,737	107,418
Taxes	$ 195,104	$ 74,850